Lack Of Misstatement Leads To Dismissal Of Stock-Drop Claims Against Drug Company

Mealey's (November 14, 2019, 4:33 PM EST) -- BOSTON — Dismissal of claims in a shareholder class action lawsuit against a biopharmaceutical company and two of its senior executives is necessary because a shareholder failed to plead any material...
To view the full article, register now.